دورية أكاديمية

P-50 Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study

التفاصيل البيبلوغرافية
العنوان: P-50 Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study
المؤلفون: García-Alfonso, P., Reina Zoilo, J., Mata Velasco, E., Llanos, M., Illán Varella, A., Safont Aguilera, M., Delgado Ureña, M., Castañón, C., Pimentel, P., Alonso Orduña, V., Mendez, J., Rivera Herrero, F., Siso, I., Rodriguez-Pascual, J., Grávalos Castro, C., Afonso, R., Fernandez Rañada, I., Grández, R., Moreno, M., López Muñoz, A., García-Paredes, B., Aranda, E.
المصدر: In Annals of Oncology July 2021 32 Supplement 3:S113-S113
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.05.105